Evidence map›Paper›PMID 34380648›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity.

Per H Nilsson, Christina Johnson, Quang Huy Quach, Alex Macpherson, Oliver Durrant, Soeren E Pischke, Hilde Fure, Anne Landsem, Grethe Bergseth, Camilla Schjalm and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Influence of Glucose onAntibiotics (Basel, Switzerland) · 2022
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Per H NilssonDepartment of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway.
Christina JohnsonDepartment of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway.
Quang Huy QuachDepartment of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway.
Alex MacphersonUCB, Slough, UK.ORCID 0000-0002-4508-5322
Oliver DurrantUCB, Slough, UK.
Soeren E PischkeDepartment of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway.ORCID 0000-0003-2543-3251
Hilde FureResearch Laboratory, Nordland Hospital, Bodø, Norway.
Anne LandsemResearch Laboratory, Nordland Hospital, Bodø, Norway.
Grethe BergsethResearch Laboratory, Nordland Hospital, Bodø, Norway.
Camilla SchjalmDepartment of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway.
Linda M Haugaard-KedströmDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Markus Huber-LangDepartment of Orthopedic Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital of Ulm, Ulm, Germany.
Jean van den ElsenDepartment of Biology and Biochemistry, University of Bath, Bath, United Kingdom.ORCID 0000-0002-0367-1956
Ole-Lars BrekkeResearch Laboratory, Nordland Hospital, Bodø, Norway.
Tom Eirik MollnesDepartment of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway; t.e.mollnes@gmail.com.ORCID 0000-0002-5785-802X
Oslo University Hospital · NONordland Hospital · NOUniversity College Birmingham · GBUniversity Hospital Ulm · DEUniversity of Bath · GBUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombin activation of C5 connects thrombosis to inflammation. Complement research in whole blood ex vivo necessitates anticoagulation, which potentially interferes with the inflammatory modulation by thrombin. We challenged the concept of thrombin as an activator of native C5 by analyzing complement activation and C5 cleavage in human whole blood anticoagulated with Gly-Pro-Arg-Pro (GPRP), a peptide targeting fibrin polymerization downstream of thrombin, allowing complete endogenous thrombin generation. GPRP dose-dependently inhibited coagulation but allowed for platelet activation in accordance with thrombin generation. Spontaneous and bacterial-induced complement activation by

Indexed as

Complement C5ThrombinBlood CoagulationComplement ActivationFibrinHumansComplement C5FibrinThrombin

Identifiers

PMID34380648
PMCPMC8428748
OpenAlexW3189469336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.